QDEL - Quidel more quick diagnosis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis

QDEL 21.31

+1.5%

Nov 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert Busse who wrote (729)	5/1/1997 9:14:00 PM
From: Mike Relyea	of 1693

Quidel's not the only biotech that's been slaughtered over the past few months. Check out the following article: investor.msn.com Biotech Stocks Under the Microscope After getting slaughtered over the past few months, some biotechnology companies are trading in the bargain basement range, and could offer some great opportunities. The trick is finding the companies with good science and intelligent management. By Richard C. Harmon, Ph.D Biotechnology investors need an aspirin just about now. They've been clobbered in the past two months. The crash has been as unexplainable as it has been harsh, with one respected analyst at a major investment banking firm declaring in an interview that his profound understanding amounts to this: "It's a combination of interest rates, tech stock blow-ups, phase of the moon, eye of newt..." Investing in biotech companies may well take as much a feel for witchcraft as it does scientific insight. Nevertheless, there are certain moments when companies with great science are offered to the public at a significant discount. This is one of those moments. . . . . Should Quidel report $0.15 for its FY97 year end, as analysts are forecasting, Quidel's P/E will be 20 at $3. A 20 P/E for a stock that's forecast to increase earnings 40% per year is a true bottom fish. I still think Quidel's going to "surprise" the analysts again, and the $0.15 forecast will be beat. Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next